Compare BOLT & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOLT | TKLF |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 8.4M |
| IPO Year | 2021 | 2020 |
| Metric | BOLT | TKLF |
|---|---|---|
| Price | $12.48 | $1.53 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $29.00 | N/A |
| AVG Volume (30 Days) | ★ 20.3K | 11.5K |
| Earning Date | 11-11-2026 | 07-10-2026 |
| Dividend Yield | N/A | ★ 16.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,695,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,525.07 | N/A |
| P/E Ratio | ★ N/A | $2.82 |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $3.10 | $1.30 |
| 52 Week High | $7.20 | $3.49 |
| Indicator | BOLT | TKLF |
|---|---|---|
| Relative Strength Index (RSI) | 80.15 | 35.72 |
| Support Level | $3.53 | $1.30 |
| Resistance Level | $7.16 | $1.63 |
| Average True Range (ATR) | 0.48 | 0.09 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 68.40 | 33.33 |
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.
Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.